Cogent Biosciences, Inc. (COGT) Stock Analysis

Free AI-powered analysis and research for Cogent Biosciences, Inc. stock

Sector: Healthcare

Analyze Cogent Biosciences, Inc. (COGT) Stock

Cogent Biosciences, Inc. (COGT) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into COGT stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Cogent Biosciences, Inc. stock.

Analyze COGT Now →

📰 Latest Update

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Wed, April 1, 2026 at 12:00 PM UTC 4 min read

Cogent Biosciences has submitted a New Drug Application (NDA) for its investigational treatment, Bezuclastinib, targeting gastrointestinal stromal tumors (GIST). This submission is significant for investors as it represents a critical step in the drug approval process, potentially expanding the company's product pipeline and market opportunities. Successful approval could lead to increased revenue and enhance Cogent's position in the oncology market.

Read full article →